NICE recommends Sobi’s Doptelet to treat thrombocytopenia
Primary ITP is a rare autoimmune condition characterised by high platelet destruction
Read More
Tag: Doptelet
Sobi launches thrombocytopenia drug Doptelet in EU
Drug will be launched in the UK first
Read More
NICE pushes Doptelet for pre-surgery liver disease treatment
Last year, the therapy received a positive opinion from the EMA’s CHMP.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
